| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 17 |
| 1 | ATEZOLIZUMAB | 8 |
| 2 | BEVACIZUMAB | 8 |
| 3 | REGORAFENIB | 8 |
| 4 | DURVALUMAB | 7 |
| 5 | TREMELIMUMAB | 6 |
| 6 | CABOZANTINIB | 5 |
| 7 | LENVATINIB | 5 |
| 8 | RIVAROXABAN | 5 |
| 9 | APIXABAN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROTAMITON | 1 | 0.0016 |
| 1 | TREMELIMUMAB | 6 | 0.0014 |
| 2 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 3 | SORAFENIB | 17 | 0.0008 |
| 4 | REGORAFENIB | 8 | 0.0007 |
| 5 | NIZATIDINE | 1 | 0.0007 |
| 6 | CEFACLOR | 1 | 0.0006 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | IOPAMIDOL | 1 | 0.0003 |
| 9 | DURVALUMAB | 7 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 7 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 3 | Bile Acid [EPC] | 2 | 0.0001 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 22 | 0.0000 |
| 7 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Factor Xa Inhibitor [EPC] | 8 | 0.0000 |